LUMOS PHARMA, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Lumos Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q4 2023.
  • Lumos Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $133M, a 9.52% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $133M +$11.6M +9.52% Dec 31, 2023 10-K 2024-03-07
Q4 2022 $122M +$8.18M +7.21% Dec 31, 2022 10-K 2024-03-07
Q4 2021 $114M +$8.24M +7.83% Dec 31, 2021 10-K 2023-03-07
Q4 2020 $105M +$95.7M +998% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $9.59M -$52.4M -84.5% Dec 31, 2019 10-K 2021-03-09
Q4 2018 $62M +$11.8M +23.5% Dec 31, 2018 10-K 2020-03-03
Q4 2017 $50.2M +$15.1M +42.9% Dec 31, 2017 10-K 2019-03-05
Q4 2016 $35.1M +$14.4M +69.7% Dec 31, 2016 10-K 2018-03-05
Q4 2015 $20.7M +$6.14M +42.2% Dec 31, 2015 10-K 2017-03-06
Q3 2015 $19.8M -$6.3M -24.1% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $9.5M -$18M -65.5% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $7.4M -$19.5M -72.5% Mar 31, 2015 10-Q/A 2015-08-24
Q4 2014 $14.6M -$10.6M -42.2% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $26.1M -$2.7M -9.38% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $27.5M +$200K +0.73% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $26.9M +$1M +3.86% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $25.2M +$2.03M +8.78% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $28.8M +$6.6M +29.7% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $27.3M +$6.1M +28.8% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $25.9M Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $23.1M +$4.28M +22.7% Dec 31, 2012 10-K 2014-03-12
Q3 2012 $22.2M Sep 30, 2012 10-Q 2012-10-31
Q2 2012 $21.2M +$2.3M +12.2% Jun 30, 2012 10-Q 2012-08-14
Q4 2011 $18.9M Dec 31, 2011 10-K 2013-03-15
Q2 2011 $18.9M Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.